Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors
This study has been completed.
Study NCT00397046   Information provided by Puma Biotechnology, Inc.

First Received on November 7, 2006.   Last Updated on May 10, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tumors
Interventions listed in this trial
neratinib
Sponsors listed in this trial
Puma Biotechnology, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services